Clinical Trials Ongoing
Clinical Trials Ongoing
2024/11/29
| Ref. No. | Disease Name | Investigational Drugs | Department | Status |
| 555 | Colorectal cancer | Serplulimab | Gastroenterology | Reqruiting |
| 552 | Lung Cancer | MK-1084 | Respiratory Medicine & Thoracic Oncology | Reqruiting |
| 550 | Hereditary Angioedema (Continued study) |
Deucrictibant | Dermatology | Reqruiting |
| 548 | Hereditary angioedema | Deucrictibant | Dermatology | Reqruiting |
| 547 | Systemic scleroderma (continued study) |
HZN-825 | Rheumatology | Reqruiting |
| 546 | Chronic kidney disease | Baxdrostat | Nephrology | Reqruiting |
| 545 | Crohn's disease | CT-P13 SC | Gastroenterology | Closed |
| 544 | Lung Cancer | Ivonescimab (SMT112) | Respiratory Medicine & Thoracic Oncology | Reqruiting |
| 543 | Lung Cancer | Datopotamab Deruxtecan、AZD2936 | Respiratory Medicine & Thoracic Oncology | Reqruiting |
| 541 | Non-alcoholic steatohepatitis | CA-NASH | Gastroenterology | Reqruiting |
| 540 | Lung Cancer | Ifinatamab delxtecan | Respiratory Medicine & Thoracic Oncology | Reqruiting |
| 539 | Interstitial lung disease | Amlitelimab/ BI 1015550 | Rheumatology | Reqruiting |
| 538 | Cardiovascular disease | LY3819469 | Cardiology | Reqruiting |
| 537 | Crohn's disease | TAK-279 | Gastroenterology | Reqruiting |
| 535 | Stomach cancer | AMG 552 | Gastroenterology | Reqruiting |
| 535 | Uterine cancer | dostarlimab | Gynecology and Oncology | Reqruiting |
| 534 | Stomach cancer | ONO-4578 | Gastroenterology | Closed |
| 533 | Ulcerative colitis (pediatric) | CNTO1959 | Pediatrics | Reqruiting |
| 531 | Progressive Lung Lines Disease | BMS-986278 | Rheumatology | Reqruiting |
| 530 | Gastroesophageal adenocarcinoma | Zanidatamab | Gastroenterology | Reqruiting |
| 529 | Chronic irritant-induced urticaria | LOU064 | Dermatology | Reqruiting |
| 527 | Ulcerative colitis | ABX464 | Gastroenterology | Reqruiting |
| 526 | Esophageal cancer (continued study) |
MK-3475 | Gastroenterology | Closed |
| 523 | Generalized strongyloidiasis | Anifrolumab | Rheumatology | Reqruiting |
| 522 | Chronic idiopathic urticaria (continued study) |
LOU064 | Dermatology | Closed |
| 521 | Lung Cancer | MK-3475A | Respiratory Medicine & Thoracic Oncology | Closed |
| 520 | Juvenile idiopathic arthritis (systemic type) |
Upadacitinib | Pediatrics | Reqruiting |
| 519 | Eosinophilic severe asthma | GSK3511294 | Respiratory Medicine & Thoracic Oncology | Closed |
| 518 | Lung Cancer | ONO-4538 | Respiratory Medicine & Thoracic Oncology | Closed |
| 517 | Hereditary angioedema | KVD900 | dermatology | Closed |
| 516 | Lung Cancer | AB122，AB154 | Respiratory Medicine & Thoracic Oncology | Closed |
| 515 | Breast Cancer | AZD9833、ZD9393 | Breast and Endocrine Surgery | Closed |
| 514 | Primary malignant spinal cord tumors | ME2906/PNL6405SCT | Department of Neurosurgery and Endovascular Therapy | Closed |
| 513 | Functional dyspepsia | Z-338 | Pediatrics | Reqruiting |
| 512 | Colorectal cancer | Tucatinib | Gastroenterology | Reqruiting |
| 511 | Symptomatic non-occlusive hypertrophic cardiac tendonopathy | mavacamten | Cardiology | Closed |
| 510 | Acid globular polypoidal vasculitis granulomatosa | GB-0998 | Rheumatology | Closed |
| 508 | Bladder cancer | FE 999326 (nadofaragene firadenovec） |
Renal urological surgery | Closed |
| 507 | Interstitial Lung disease | BI 1015550 | Rheumatology | Closed |
| 506 | Lung Cancer | AB122 | Respiratory Medicine & Thoracic Oncology | Reqruiting |
| 505 | Generalized strongyloidiasis | BI 685509 | Rheumatology | Closed |
| 500 | Cardiovascular disease | Obicetrapib | Cardiology | Closed |
| 499 | Cardiovascular disease | Obicetrapib | Cardiology | Closed |
| 498 | Lung Cancer | MK-7684A | Respiratory Medicine & Thoracic Oncology | Reqruiting |
| 497 | Generalized strongyloidiasis | HZN-825 | Nephrology | Closed |
| 496 | Ulcerative colitis | RPC1063 | Pediatrics | Reqruiting |
| 495 | Esophageal cancer | MK-7902（E7080）/ MK-3475 | Gastroenterology | Reqruiting |
| 492 | Protoporphyria | MT-7117 | Dermatology | Closed |
| 490 | Lung Cancer | ONO-4578／ONO-4538 | Respiratory Medicine & Thoracic Oncology | Closed |
| 488 | SLE | BIIB059 | Rheumatology | Closed |
| 486 | Colorectal cancer | ONO-7913／ONO-4538 | Gastroenterology | Closed |
| 484 | Lung Cancer | BMS-986012／Nivolumab | Respiratory Medicine & Thoracic Oncology | Closed |
| 483 | Lung Cancer | MK-3475 | Respiratory Medicine & Thoracic Oncology | Closed |
| 481 | Colorectal cancer | Encorafenib | Gastroenterology | Closed |
| 479 | Lung Cancer | MK-7684A | Respiratory Medicine & Thoracic Oncology | Closed |
| 470 | Colorectal cancer | ONO-4578／ONO-4538 | Gastroenterology | Closed |
| 465 | Ulcerative colitis | CP 690,550 | Gastroenterology | Closed |
| 464 | Lung Cancer | MK-7339 | Respiratory Medicine & Thoracic Oncology | Closed |
| 458 | Lung Cancer | MK-7339 | Respiratory Medicine & Thoracic Oncology | Closed |
| 453 | Bladder Cancer | MK-3475 | Renal Urological Surgery | Closed |
| 452 | Lung Cancer | MK-3475 | Respiratory Medicine & Thoracic Oncology | Closed |
| 451 | Crohn's Disease | ABT-494 | Gastroenterology | Closed |
| 443 | Generalized Juvenile Onset Arthritis | Baricitinib | Pediatrics | Reqruiting |
| 442 | Endometrial atypical proliferation, uterine cancer |
Medroxyprogesterone/ Metformin |
Gynecology and Oncology | Closed |
| 439 | Recurrent high-grade meningioma | SPM-011/BNCT | Neurosurgery and Endovascular Therapy | Closed |
| 437 | Bladder cancer | Nivolumab | Renal urological surgery | Closed |
| 432 | Juvenile Onset Arthritis | Baricitinib | Pediatrics | Reqruiting |
| 423 | Lung Cancer | REGN2810 | Respiratory Medicine & Thoracic Oncology | Closed |
| 417 | Urothelial carcinoma | Nivolumab/ipilimumab | Renal urological surgery | Closed |
| 411 | Stomach cancer | MK-3475 | Gastroenterology | Closed |
| 371 | Lung Cancer | BMS-936558 | Respiratory Medicine & Thoracic Oncology | Closed |
